This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches
Co-organized by the Universitätsklinikum FAU Erlangen and COST Action CA17118 (TRANSCOLONCAN)
Wrap-up meeting before the final conference in June 2022. The first meeting in Skopje (North Macedonia) in 2019 also gathered together all WGs.
The main objective is to continue collaborations, produce expected outputs and decide how to continue this network for each WG. This meeting will take place during 3 days to permit more discussions and interactions.